Istituto Oncologico Veneto Irccs
Clinical trials sponsored by Istituto Oncologico Veneto Irccs, explained in plain language.
-
Milk thistle compound tested against brain cancer in new trial
Disease control Recruiting nowThis study tests whether adding silibinin (a milk thistle extract) to standard chemoradiation and maintenance therapy can delay tumor growth in people with a specific type of newly diagnosed glioblastoma. About 110 participants will receive either silibinin or a placebo alongside…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New dressing aims to cut wound issues in limb sarcoma surgery
Disease control Recruiting nowThis study tests whether a single-use negative pressure wound dressing (PICO14) can reduce wound complications after surgery for soft tissue sarcoma of the limbs in patients who had radiation therapy. About 48 adults will be randomly assigned to receive either the special dressin…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for brain tumor patients: drug shows promise in slowing recurrent meningioma
Disease control Recruiting nowThis study tests a drug called regorafenib in people whose meningioma (a type of brain tumor) has come back after previous treatment. The drug works by blocking blood vessel growth and other signals that help tumors grow. About 104 participants will receive the drug to see if it …
Phase: PHASE2 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Electric shocks and chemo: new hope for inoperable tumors?
Disease control Recruiting nowThis study tests a treatment called electrochemotherapy for people with tumors in organs like the liver or pancreas that cannot be removed with surgery. The treatment uses short electric pulses to help chemotherapy drugs enter cancer cells more effectively. The goal is to see if …
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Virtual reality headsets tested to calm nerves during urology procedures
Symptom relief Recruiting nowThis study tests whether using a virtual reality headset (REALICA) can help reduce pain and anxiety in people undergoing common outpatient urology procedures like prostate biopsy, cystoscopy, or circumcision. About 56 adults will use the VR device during their procedure and repor…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Symptom relief
Last updated May 16, 2026 22:28 UTC
-
New bladder rinse aims to calm cancer Treatment's harsh side effects
Symptom relief Recruiting nowThis study is for 200 adults with non-muscle invasive bladder cancer who are getting standard chemotherapy (MMC) or immunotherapy (BCG) directly into the bladder. Half will also receive a special bladder rinse called Hydeal Cyst® after each treatment. The goal is to see if this r…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Symptom relief
Last updated May 06, 2026 16:02 UTC
-
Scientists hunt for weakness in T-Cell cancers
Knowledge-focused Recruiting nowThis study looks for new ways to kill T-cell leukemia and lymphoma cells by changing their internal chemical balance. Researchers will test drug combinations in the lab using cells from 120 adult patients. The goal is to find treatments that can overcome drug resistance in these …
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated May 16, 2026 22:29 UTC
-
Scarless breast cancer surgery under the microscope: does it work?
Knowledge-focused Recruiting nowThis study reviews 250 women who had breast-conserving surgery with a special flap technique that leaves no visible scar on the breast. The goal is to see how often cancer comes back at the edge of the removed tissue and how well the breast looks and feels afterward. Researchers …
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated May 08, 2026 12:02 UTC
-
Scientists dig into Mesothelioma's genetic secrets to personalize care
Knowledge-focused Recruiting nowThis study looks at tumor samples from 220 people with pleural or peritoneal mesothelioma, a rare cancer linked to asbestos. Researchers will analyze genes and immune cells in the tumors to identify patterns that predict how well different treatments work. The goal is to better u…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated May 07, 2026 18:43 UTC